Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

OSPREY: PSMA-targeted PET/CT imaging in prostate cancer patients

Dr Frédéric Pouliot - Centre Hospitalier Universitaire (CHU) de Quebec
OSPREY: PSMA-targeted PET/CT imaging in prostate cancer patients ( Dr Frédéric Pouliot - Centre Hospitalier Universitaire (CHU) de Quebec )
18 Feb 2020

Sitravatinib and nivolumab combo for advanced clear cell renal cell cancer

Dr Pavlos Msaouel - The University of Texas MD Anderson Cancer Center, Houston, USA
Sitravatinib and nivolumab combo for advanced clear cell renal cell cancer ( Dr Pavlos Msaouel - The University of Texas MD Anderson Cancer Center, Houston, USA )
14 Feb 2020

BLASST-1: Combining nivolumab, gemcitabine and cisplatin for the neoadjuvant treatment of muscle invasive bladder cancer

Dr Shilpa Gupta - Case Comprehensive Cancer Center, Cleveland, USA
BLASST-1: Combining nivolumab, gemcitabine and cisplatin for the neoadjuvant treatment of muscle invasive bladder cancer ( Dr Shilpa Gupta - Case Comprehensive Cancer Center, Cleveland, USA )
14 Feb 2020

Management of patients with advanced seminoma

Prof Peter Albers - Düsseldorf University, Düsseldorf, Germany
Management of patients with advanced seminoma ( Prof Peter Albers - Düsseldorf University, Düsseldorf, Germany )
14 Feb 2020

CHHip: Conventional versus hypofractionated high-dose intensity modulated radiotherapy for localised prostate cancer

Prof David Dearnaley - Institute of Cancer Research, London, UK
CHHip: Conventional versus hypofractionated high-dose intensity modulated radiotherapy for localised prostate cancer ( Prof David Dearnaley - Institute of Cancer Research, London, UK )
14 Feb 2020

ASCO GU 2020: Updates in renal cancer

Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
ASCO GU 2020: Updates in renal cancer ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
14 Feb 2020

Beyond p-values: When does clinical impact outweigh statistical significance?

Prof Matthew Sydes - University College London, London, UK
Beyond p-values: When does clinical impact outweigh statistical significance? ( Prof Matthew Sydes - University College London, London, UK )
14 Feb 2020

Prostate-specific membrane antigen PET: Who should undergo advanced imaging?

Dr Jérémie Calais - David Geffen School of Medicine UCLA, Los Angeles, USA
Prostate-specific membrane antigen PET: Who should undergo advanced imaging? ( Dr Jérémie Calais - David Geffen School of Medicine UCLA, Los Angeles, USA )
14 Feb 2020

Treatment of advanced stage cervical and ovarian cancer

Dr Shona Nag - Sahyadri Hospitals, Pune, India
Treatment of advanced stage cervical and ovarian cancer ( Dr Shona Nag - Sahyadri Hospitals, Pune, India )
14 Feb 2020

Treatment of advanced stage breast cancer

Dr Shona Nag - Sahyadri Hospitals, Pune, India
Treatment of advanced stage breast cancer ( Dr Shona Nag - Sahyadri Hospitals, Pune, India )
14 Feb 2020

Cancer genetics in the clinic: Ready for 'prime time'?

Dr Ophira Ginsburg - NYU Langone Health, New York City, USA
Cancer genetics in the clinic: Ready for 'prime time'? ( Dr Ophira Ginsburg - NYU Langone Health, New York City, USA )
14 Feb 2020

How to communicate when the goals of care change

Dr. Naveen Salins - Kasturba Hospital, Manipal, India
How to communicate when the goals of care change ( Dr. Naveen Salins - Kasturba Hospital, Manipal, India )
14 Feb 2020